TopoTarget A/S
Symbion
Fruebjergvej 3
DK 2100 Copenhagen
Denmark
Tel: +45 39 17 83 92
Fax: +45 39 17 94 92
CVR-nr: 25695771
www.topotarget.com
To the Copenhagen Stock Exchange
Announcement No. 23-07 / Copenhagen 26 June 2007
Report pursuant to the Danish Securities Trading Act, Section 28a
Copenhagen - 26 June 2007 - Pursuant to the Danish Securities Trading Act,
Section 28a TopoTarget A/S (Copenhagen Stock Exchange: TOPO) is obliged to
report on transactions by members of its senior management and their related
parties in shares issued by TopoTarget A/S and related securities.
Name Peter Buhl Jensen
Reason CEO
Issuer and ISIN code TopoTarget A/S, DK0060086072
Transaction Purchase
Trade date 25 June 2007
Market Copenhagen Stock Exchange
Number 10,010
Market value in DKK 300,300
Name Leif Hamø
Reason CFO
Issuer and ISIN code TopoTarget A/S, DK0060086072
Transaction Purchase
Trade date 25 June 2007
Market Copenhagen Stock Exchange
Number 26,677
Market value in DKK 800,310
TopoTarget A/S
For further information, please contact:
Dr. Peter Buhl Jensen Telephone +45 39 17 83 41
Chief Executive Officer Mobile +45 21 60 89 22
Background information
About TopoTarget
TopoTarget (OMX - The Nordic Exchange: TOPO) is a biopharmaceutical company,
headquartered in Denmark and with subsidiaries in the UK, Germany and the USA,
dedicated to finding ''Answers for Cancer'' and developing improved cancer
therapies. TopoTarget is founded and run by clinical cancer specialists and
combines years of hands-on clinical experience with in-depth understanding of
the molecular mechanisms of cancer. Focus lies on highly predictive cancer
models and key cancer enzyme regula-tors (mainly HDAC, mTOR, and topoisomerase
II inhibitors) and a strong development foundation has been built. TopoTarget
has a broad portfolio of small molecule preclini-cal drug candidates and seven
drugs are in clinical development, including both novel anti-cancer
therapeutics and new cancer indications for existing drugs. Savene™ is
TopoTarget's first product on the market. In addition to organic growth,
TopoTarget consistently looks for opportunities to strengthen and expand its
activities through acquisitions and in-licensing. For more information, please
refer to www.topotarget.com.
